Exosomal miR-19a derived from melanoma cell promotes the vemurafenib resistance of malignant melanoma through directly targeting LRIG1 to reactivate AKT and MAPK pathway

Update your browser to view ScienceDirect.

Request details:

Request ID: 89fe9e91591a17d1-SJC
IP: 116.62.10.13
UTC time: 2024-07-08T08:14:12+00:00
Browser: Mozilla/5.0 (X11; U; Linux x86_64; en-US; rv:1.9.1.4) Gecko/20091030 Gentoo Firefox/3.5.4